Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children

Journal of Microbiology, Immunology and Infection

Volumn 47, Issue 6, 2014, Pages 455-461

  Yun, Ki Wook ^a   Kim, Hak Young ^a   Park, Hee Kuk ^a   Kim, Wonyong ^a   Lim, In Seok ^a  

^a Chung Ang University   (South Korea)

Author keywords

Asymptomatic bacteriuria; Urinary tract infection; Uropathogenic Escherichia coli; Virulence genes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL PROTEIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FEOB PROTEIN; FYUA PROTEIN; GENTAMICIN; LEVOFLOXACIN; PAPEF PROTEIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL DNA; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; UNIVERSITY HOSPITAL; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; BACTERIURIA; COMPARATIVE STUDY; ESCHERICHIA COLI INFECTION; GENETICS; HOSPITAL; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; SOUTH KOREA;

BACTERIURIA; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; REPUBLIC OF KOREA; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 84908572622     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.07.010     Document Type: Article

References (36)

1. Montini G., Tullus K., Hewitt I. Febrile urinary tract infections in children. N Engl J Med 2011, 365:239-250.
2. Yang C.C., Shao P.L., Lu C.Y., Tsau Y.K., Tsai I.J., Lee P.I., et al. Comparison of acute lobar nephronia and uncomplicated urinary tract infection in children. J Microbiol Immunol Infect 2010, 43:207-214.
3. Hooton T.M., Scholes D., Stapleton A.E., Roberts P.L., Winter C., Gupta K., et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000, 343:992-997.
4. Colgan R., Nicolle L.E., McGlone A., Hooton T.M. Asymptomatic bacteriuria in adults. Am Fam Physician 2006, 74:985-990.
5. Ramos N.L., Dzung D.T., Stopsack K., Janko V., Pourshafie M.R., Katouli M., et al. Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries. Eur J Clin Microbiol Infect Dis 2011, 30:1587-1593.
6. Lee J.C., Lee N.Y., Lee H.C., Huang W.H., Tsui K.C., Chang C.M., et al. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community. J Microbiol Immunol Infect 2012, 45:127-133.
7. Kim Y.B., Kim S.Y., Lim E.G. Virulence factors and genotyping of enterotoxigenic Escherichia coli O128 isolates from clinical specimens. J Korean Soc Microbiol 1999, 34:211-220.
8. Bogyiova E., Siegfried L., Kmetova M., Sandorcinova Z., Liptakova A., Biros E. Occurrence and genetic association of selected virulence factors in clinical Escherichia coli isolates. Folia Microbiol 2002, 47:73-77.
9. Chiou Y.Y., Chen M.J., Chiu N.T., Lin C.Y., Tseng C.C. Bacterial virulence factors are associated with occurrence of acute pyelonephritis but not renal scarring. J Urol 2010, 184:2098-2102.
10. Cusumano C.K., Hung C.S., Chen S.L., Hultgren S.J. Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis. Infect Immun 2010, 78:1457-1467.
11. Crepin S., Houle S., Charbonneau M.E., Mourez M., Harel J., Dozois C.M. Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection. Infect Immun 2012, 80:2802-2815.
12. Gao Q., Wang X., Xu H., Xu Y., Ling J., Zhang D., et al. Roles of iron acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin and aerobactin contribute more to virulence than heme in a chicken infection model. BMC Microbiol 2012, 12:143.
13. Zdziarski J., Svanborg C., Wullt B., Hacker J., Dobrindt U. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?. Infect Immun 2008, 76:695-703.
14. Salvador E., Wagenlehner F., Kohler C.D., Mellmann A., Hacker J., Svanborg C., et al. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 2012, 80:668-678.
15. Wang M.C., Tseng C.C., Wu A.B., Lin W.H., Teng C.H., Yan J.J., et al. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J Microbiol Immunol Infect 2013, 46:24-29.
16. Johnson J.R., Stell A.L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000, 181:261-272.
17. Yamamoto S., Terai A., Yuri K., Kurazono H., Takeda Y., Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 1995, 12:85-90.
18. Schubert S., Rakin A., Karch H., Carniel E., Heesemann J. Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun 1998, 66:480-485.
19. Nakano M., Yamamoto S., Terai A., Ogawa O., Makino S.I., Hayashi H., et al. Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein. FEMS Microbiol Lett 2001, 205:71-76.
20. Raz R. Asymptomatic bacteriuria. Clinical significance and management. Int J Antimicrob Agents 2003, 22(Suppl. 2):S45-S47.
21. Nicolle L.E. Asymptomatic bacteriuria: review and discussion of the IDSA guidelines. Int J Antimicrob Agents 2006, 28(Suppl. 1):S42-S48.
22. Roos V., Nielsen E.M., Klemm P. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 2006, 262:22-30.
23. Cai T., Mazzoli S., Mondaini N., Meacci F., Nesi G., D'Elia C., et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?. Clin Infect Dis 2012, 55:771-777.
24. Roos V., Ulett G.C., Schembri M.A., Klemm P. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun 2006, 74:615-624.
25. Bonacorsi S., Houdouin V., Mariani-Kurkdjian P., Mahjoub-Messai F., Bingen E. Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia. J Clin Microbiol 2006, 44:1156-1158.
26. Cheng C.H., Tsau Y.K., Su L.H., Lin C.L., Lin T.Y. Comparison of urovirulence factors and genotypes for bacteria causing acute lobar nephronia and acute pyelonephritis. Pediatr Infect Dis J 2007, 26:228-232.
27. Bien J., Sokolova O., Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012, 2012:681473.
28. Oliveira F.A., Paludo K.S., Arend L.N., Farah S.M., Pedrosa F.O., Souza E.M., et al. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet Mol Res 2011, 10:4114-4125.
29. Le Bouguenec C., Archambaud M., Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 1992, 30:1189-1193.
30. Zgur-Bertok D., Modric E., Grabnar M. Aerobactin uptake system, ColV production, and drug resistance encoded by a plasmid from an urinary tract infection Escherichia coli strain of human origin. Can J Microbiol 1990, 36:297-299.
31. Garcia T.A., Ventura C.L., Smith M.A., Merrell D.S., O'Brien A.D. Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder. Infect Immun 2013, 81:99-109.
32. Mabbett A.N., Ulett G.C., Watts R.E., Tree J.J., Totsika M., Ong C.L., et al. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 2009, 299:53-63.
33. Cheng C.H., Tsau Y.K., Kuo C.Y., Su L.H., Lin T.Y. Comparison of extended virulence genotypes for bacteria isolated from pediatric patients with urosepsis, acute pyelonephritis, and acute lobar nephronia. Pediatr Infect Dis J 2010, 29:736-740.
34. Zhao L., Chen X., Zhu X., Yang W., Dong L., Xu X., et al. Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China). Urology 2009, 74:702-707.
35. Houdouin V., Bonacorsi S., Bidet P., Bingen-Bidois M., Barraud D., Bingen E. Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 2006, 58:748-751.
36. Piatti G., Mannini A., Balistreri M., Schito A.M. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 2008, 46:480-487.